What is the role of PARP inhibitors in pancreatic cancer?

Ritika Halder, Rachna T. Shroff

Research output: Contribution to journalEditorialpeer-review

3 Scopus citations
Original languageEnglish (US)
Pages (from-to)913-918
Number of pages6
JournalExpert Review of Anticancer Therapy
Issue number11
StatePublished - Nov 2020


  • BRCA mutation
  • DNA damage response
  • olaparib
  • pancreatic adenocarcinoma
  • Pancreatic cancer
  • PARP inhibitor
  • polyadenosine diphosphate-ribose polymerase
  • rucaparib
  • targeted therapy
  • veliparib

ASJC Scopus subject areas

  • Oncology
  • Pharmacology (medical)

Cite this